4//SEC Filing
AMGEN INC 4
Accession 0001127602-14-004399
$AMGNCIK 0000318154operating
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 6:08 PM ET
Size
5.9 KB
Accession
0001127602-14-004399
Insider Transaction Report
Form 4
AMGEN INCAMGN
SCOTT DAVID J
Sr. VP, Gen. Counsel & Secy.
Transactions
- Award
Common Stock
2014-01-31+3,362→ 79,053 total
Footnotes (3)
- [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 1/31/2016, 1/31/2017 and 1/31/2018, respectively.
- [F2]These shares include the following RSUs granted under the Company's equity plans: 1,450 RSUs which fully vest on 4/26/2014; 22,081 RSUs which fully vest on 12/31/2014; 7,504 RSUs which vest in one installment of 3,696 on 4/25/2014 and one installment of 3,808 on 4/25/2015; 6,141 RSUs which vest in three installments of 2,026, 2,027 and 2,088 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively; 5,374 RSUs which vest in two equal installments of 1,773 each on 1/28/2015 and 1/28/2016 and one installment of 1,828 on 1/28/2017; and 3,362 RSUs which vest in two equal installments of 1,109 on 1/31/2016 and 1/31/2017 and one installment of 1,144 on 1/31/2018. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- [F3]These shares include 296 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
Documents
Issuer
AMGEN INC
CIK 0000318154
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000318154
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 6:08 PM ET
- Size
- 5.9 KB